Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.072 AUD | -4.00% | +26.32% | +227.27% |
Apr. 30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
Apr. 18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+227.27% | 8.5M | |
+48.39% | 765B | |
-6.13% | 354B | |
+20.61% | 331B | |
+10.00% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.80% | 164B | |
-2.50% | 162B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Completes Preclinical Studies on Cholesterol Lowering Medication